Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Uterine fibroids Stories

2009-11-17 04:55:00

ANDOVER, Mass., Nov. 17 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the United States. In conjunction with the announcement, Smith & Nephew will host a panel discussion today about hysteroscopy at this year's American Association of Gynecologic Laparoscopists (AAGL) annual meeting, which is being held in Orlando, Fla. The...

2009-11-11 07:00:00

TIRAT CARMEL, Israel, November 11 /PRNewswire/ -- InSightec Ltd. today announced that three new papers published in the November issue of Ultrasound in Obstetrics and Gynecology add to the growing body of data supporting the use of ExAblate(R) as a safe, effective and durable treatment for uterine fibroids. One study showed that non-invasive treatment with the ExAblate Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system offers women a significantly less risky treatment for...

2009-10-13 13:06:00

NEWNAN, Ga., Oct. 13 /PRNewswire/ -- CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product. (Logo: http://www.newscom.com/cgi-bin/prnh/20081001/CLW080LOGO-b ) (Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-b ) (Photo: http://www.newscom.com/cgi-bin/prnh/20090916/CL76973) In...

428061dbbbc725a16d29bcdf101c2ecc1
2009-08-13 13:00:00

New England Journal of Medicine highlights benefits of uterine fibroid embolization in clinical therapeutics article; UFE could decrease hysterectomy rate in United StatesUterine fibroid embolization"”a minimally invasive interventional radiology treatment for women that cuts off blood flow to painful fibroids to kill the tumors"”is highlighted as an appropriate treatment for women in a Clinical Therapeutics article in the Aug. 13 issue of the New England Journal of Medicine."UFE...

2009-08-13 07:07:00

New England Journal of Medicine Highlights Benefits of Uterine Fibroid Embolization in Clinical Therapeutics Article; UFE Could Decrease Hysterectomy Rate in United States FAIRFAX, Va., Aug. 13 /PRNewswire-USNewswire/ -- Uterine fibroid embolization--a minimally invasive interventional radiology treatment for women that cuts off blood flow to painful fibroids to kill the tumors--is highlighted as an appropriate treatment for women in a Clinical Therapeutics article in the Aug. 13 issue of...

2009-07-14 10:47:00

Journal of Vascular and Interventional Radiology Assembles Major Studies of Uterine Artery Embolization Over Past Two Years; Treatment Replaces Need for Traditional Surgery FAIRFAX, Va., July 14 /PRNewswire-USNewswire/ -- For the first time, the Society of Interventional Radiology has assembled a major electronic collection of professional articles about uterine artery embolization, a treatment directed toward a number of conditions involving the uterus -- most often adverse health...

2009-04-22 09:13:00

National OB-GYN Group States Uterine Artery Embolization 'Safe and Effective' for Appropriately Selected Patients FREDERICKSBURG, Va., April 22 /PRNewswire/ -- Women with painful uterine fibroids are more likely to opt for a minimally invasive procedure over hysterectomy in the months ahead. That's the prediction of Virginia Interventional and Vascular Associates (VIVA) doctors following a bulletin on uterine artery embolization by The American College of Obstetricians and Gynecologists....

2009-04-21 09:00:00

Reflects Robust Growth of Client Intuitive Surgical's da Vinci(R) System GREAT BARRINGTON, Mass., April 21 /PRNewswire/ -- The Chamberlain Group, producers of anatomically accurate surgical trainers, today announced their new Uterine Robotic Surgery Trainer. The trainer is a lifelike, full-scale model of the human uterus and vaginal canal. It is composed of Chamberlain's proprietary polymer that looks and feels like living tissue, has appropriate elasticity and can be cut and sutured. The...

2009-04-07 07:00:00

TIRAT CARMEL, Israel, April 7 /PRNewswire/ -- InSightec Ltd. announced today that the U.S. Food and Drug Administration (FDA) approved a label change for the company's ExAblate(R) 2000 MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with non-hysteroscopically resectable uterine fibroids. Under the new labeling, the agency allows physicians to treat up to 100% of the fibroid compared to its previous restriction to only treat up to half the fibroid tissue. "In...

2009-03-19 04:14:00

TIRAT CARMEL, Israel, March 19 /PRNewswire/ -- InSightec Ltd. reported today that it has closed an internal round of financing totaling US$15 million from its existing investors. Elbit Imaging Ltd. (NASDAQ: EMITF) ("EI") has invested US$7.5M on March 18, 2009. Additional US$7.5M would be invested no later than 12 months following the date hereof by its existing investors. The investment will take the form of Preferred Shares B, which are convertible to InSightec's ordinary...